The prevalence of Mycoplasma pneumoniae in children in Shandong, China before, during, and after COVID-19
- PMID: 39722766
- PMCID: PMC11668564
- DOI: 10.3389/fped.2024.1479311
The prevalence of Mycoplasma pneumoniae in children in Shandong, China before, during, and after COVID-19
Abstract
Background: The multifaceted non-pharmaceutical interventions after the outbreak of the COVID-19 pandemic not only limited the spread of SARS-CoV2 but also had an impact on the prevalence of other pathogens.
Methods: In this work, we retrospectively analyzed the epidemiological characteristics of Mycoplasma pneumoniae (MP) in children before and after the COVID-19 pandemic in Shandong, China. From 2019-2023, there were 29,558 visits of pediatric patients (1 month to 15 years old) with respiratory tract infection (RTI) symptoms at a tertiary hospital in Shandong Province, 10,039 of which were positive for MP according to a passive agglutination assay of the serum IgM antibodies. Conduct statistical analysis and epidemiological investigation of the test results categorized by years, months, ages, genders and clinical diagnosis. Utilize the χ 2 test to analyze the differences in incidence rates.
Results: Compared to 2019, the number of visits and the positive cases both decreased substantially in 2020, but the positivity rate increased. Both 2021 and 2023 were peak years of MP infection. The peak seasons of MP infection were fall and winter, female patients had higher positivity rate than male patients, and school-age children (>6 years) had higher positivity rate than the children in other age groups. In terms of the clinical manifestation of MP infection, compared to 2019, in 2023, the proportion of bronchopneumonia and upper RTI decreased significantly.
Conclusions: The ongoing surveillance of the epidemiology of MP is critical for effective disease management and provides a basis for diagnosis, treatment, and the corresponding prevention and control strategies. This work for the first time characterized the epidemiology of MP in Shandong before and after the COVID-19 pandemic, thus providing valuable information for monitoring and preventing MP infection in the post-epidemic era.
Keywords: COVID-19; China; Mycoplasma pneumoniae; children; epidemiological study.
© 2024 Kong, Wang, Zhuo and Zhuang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Mycoplasma pneumoniae detections in children with lower respiratory infection before and during the COVID-19 pandemic: a large sample study in China from 2019 to 2022.BMC Infect Dis. 2024 Jun 1;24(1):549. doi: 10.1186/s12879-024-09438-2. BMC Infect Dis. 2024. PMID: 38824572 Free PMC article.
-
Childhood Mycoplasma pneumoniae: epidemiology and manifestation in Northeast and Inner Mongolia, China.Microbiol Spectr. 2024 May 2;12(5):e0009724. doi: 10.1128/spectrum.00097-24. Epub 2024 Apr 12. Microbiol Spectr. 2024. PMID: 38606996 Free PMC article.
-
Epidemiological Study on Mycoplasma pneumoniae and Chlamydia pneumoniae Infection of Hospitalized Children in a Single Center During the COVID-19 Pandemic.Front Cell Infect Microbiol. 2022 Mar 21;12:843463. doi: 10.3389/fcimb.2022.843463. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35386684 Free PMC article.
-
Influence of non-pharmaceutical interventions on epidemiological characteristics of Mycoplasma pneumoniae infection in children during and after the COVID-19 epidemic in Ningbo, China.Front Microbiol. 2024 Jul 17;15:1405710. doi: 10.3389/fmicb.2024.1405710. eCollection 2024. Front Microbiol. 2024. PMID: 39086655 Free PMC article.
-
Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China.Front Cell Infect Microbiol. 2024 Aug 16;14:1424554. doi: 10.3389/fcimb.2024.1424554. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39220288 Free PMC article.
Cited by
-
The Clinical Profile of Pediatric M. pneumoniae Infections in the Context of a New Post-Pandemic Wave.Microorganisms. 2025 May 17;13(5):1152. doi: 10.3390/microorganisms13051152. Microorganisms. 2025. PMID: 40431322 Free PMC article.
References
-
- Edens C, Clopper BR, DeVies J, Benitez A, McKeever ER, Johns D, et al. Notes from the field: reemergence of mycoplasma pneumoniae infections in children and adolescents after the COVID-19 pandemic, United States, 2018–2024. MMWR Morb Mortal Wkly Rep. (2024) 73(7):149–51. 10.15585/mmwr.mm7307a3 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous